Guggenheim Downgrades Celgene (CELG) to Neutral Following Acquisition

January 4, 2019 4:04 AM EST Send to a Friend
Guggenheim analyst Seamus Fernandez downgraded Celgene (NASDAQ: CELG) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login